Clover Health Q3 net income reaches $6.4 million; full-year 2026 guidance raised
Clover Health reported third-quarter 2026 GAAP net income of $6.4 million, compared with a loss of $24.4 million a year earlier, on total revenues of $759.3 million, up 52.9%. The company raised its full-year 2026 guidance for total revenues, GAAP net income and Adjusted EBITDA, and its board made Clay Thornton permanent Chief Financial Officer effective November 4, 2026.
Key points
- Q3 2026 total revenues were $759.3 million, up 52.9% year over year; Q3 2026 Consolidated Gross profit was $129.8 million, up 77.3%.
- Full-year 2026 GAAP net income guidance is now $25 million to $35 million, up from $20 million to $35 million previously.
- Full-year 2026 total revenues guidance is now $2.97 billion to $3.00 billion, up from $2.92 billion to $3.00 billion previously.
- Clay Thornton was appointed permanent CFO effective November 4, 2026, with a base salary of $450,000; Joseph Oldakowski was named Chief Accounting Officer with a base salary of $410,000.
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.